Segment and Geographic Information (Details) - USD ($) |
3 Months Ended | 9 Months Ended | 12 Months Ended | |||||||
|---|---|---|---|---|---|---|---|---|---|---|
Sep. 30, 2025 |
Jun. 30, 2025 |
Mar. 31, 2025 |
Sep. 30, 2024 |
Jun. 30, 2024 |
Mar. 31, 2024 |
Sep. 30, 2025 |
Sep. 30, 2024 |
Dec. 31, 2024 |
Dec. 31, 2023 |
|
| Segment and Geographic Information | ||||||||||
| Total revenues | $ 7,361,889 | $ 5,236,990 | $ 13,836,811 | $ 11,840,189 | $ 17,406,185 | $ 17,625,370 | ||||
| Research and development expenses | (473,303) | 0 | (1,335,464) | 0 | ||||||
| Consolidated net (loss) income | $ (1,541,916) | $ (1,679,220) | (457,546) | $ (6,146,914) | $ (2,854,875) | (10,802,111) | 5,668,314 | |||
| Segment And Geographic Information [Member] | ||||||||||
| Segment and Geographic Information | ||||||||||
| Material sales | 4,715,874 | 5,092,123 | 10,637,304 | 11,479,147 | 14,481,784 | 17,092,996 | ||||
| License fees | 2,600,000 | 133,125 | 3,125,000 | 273,750 | 2,808,125 | 387,500 | ||||
| Other revenues | 46,015 | 11,742 | 74,507 | 87,292 | 116,276 | 144,874 | ||||
| Total revenues | 7,361,889 | 5,236,990 | 13,836,811 | 11,840,189 | 17,406,185 | 17,625,370 | ||||
| Material costs | (2,557,924) | (2,829,784) | (5,736,069) | (6,055,177) | (7,686,447) | (8,898,747) | ||||
| Blending and milling | (110,518) | (127,786) | (268,643) | (312,410) | (377,598) | (769,167) | ||||
| Shipping | (339,987) | (417,997) | (821,308) | (941,768) | ||||||
| Other cost of goods sold | (197,856) | (151,095) | (452,507) | (417,317) | (700,279) | (652,688) | ||||
| Compensation and benefits | (1,219,307) | (1,031,223) | (3,664,564) | (5,284,900) | ||||||
| Stock-based compensation | (19,641) | (133,631) | (99,596) | (1,040,625) | ||||||
| Amortization and depreciation | (105,667) | (64,830) | (281,796) | (184,989) | (248,084) | (228,962) | ||||
| Consulting fees | (344,043) | (103,057) | (911,017) | (403,197) | (879,800) | (109,381) | ||||
| Professional fees | (1,387,156) | (963,256) | (2,409,608) | (3,056,291) | (4,722,313) | (9,717,572) | ||||
| General and administrative | (203,872) | (511,456) | (732,212) | (1,198,807) | (1,588,129) | (1,471,311) | ||||
| Change in fair value of profit share | (37,619) | 282,381 | (766,667) | (2,672,253) | (3,959,065) | (11,209,677) | ||||
| Interest expense | 0 | (7,356) | (54) | (258,990) | ||||||
| Income tax benefit (expense) | (1,611) | 283,898 | (37,391) | 269,717 | ||||||
| Research and development expenses | (64,088) | 0 | (154,725) | 0 | ||||||
| Interest income | 15,412 | 80,656 | 66,222 | 257,483 | 293,524 | 79,301 | ||||
| Segment net (loss) income | 788,012 | (457,546) | (2,433,124) | (9,459,335) | (10,802,111) | 5,668,314 | ||||
| Adjustments and reconciling items | 0 | 0 | 0 | 0 | ||||||
| Consolidated net (loss) income | $ 788,012 | $ (457,546) | $ (2,433,124) | $ (9,459,335) | $ (10,802,111) | $ 5,668,314 | ||||
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition Cost of material used for good produced and service rendered. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Amount of current income tax expense (benefit) pertaining to taxable income (loss) from continuing operations. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to other adjustments. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition The amount of interest income and other income recognized during the period. Included in this element is interest derived from investments in debt securities, cash and cash equivalents, and other investments which reflect the time value of money or transactions in which the payments are for the use or forbearance of money and other income from ancillary business-related activities (that is, excluding major activities considered part of the normal operations of the business). No definition available.
|
| X | ||||||||||
- Definition The portion of profit or loss for the period, net of income taxes, which is attributable to the parent. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Other costs incurred during the reporting period related to other revenue generating activities. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount of expense charged against earnings to allocate the cost of tangible and intangible assets over their remaining economic lives, classified as other. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount of noninterest expense classified as other. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Cash received from licensees for license fees during the current period. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition A fee charged for services from professionals such as doctors, lawyers and accountants. The term is often expanded to include other professions, for example, pharmacists charging to maintain a medicinal profile of a client or customer. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Amount of expense for research and development. Includes, but is not limited to, cost for computer software product to be sold, leased, or otherwise marketed and writeoff of research and development assets acquired in transaction other than business combination or joint venture formation or both. Excludes write-down of intangible asset acquired in business combination or from joint venture formation or both, used in research and development activity. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss). Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Amount of sales-type lease revenue. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. No definition available.
|
| X | ||||||||||
- Definition Amount of operating expense for products and services of regulated operation. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Details
|